During the past decade, St. Luke's Cancer Network at St. Luke's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Cancer Network at St. Luke's Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 7 trials, followed by "Eastern Cooperative Oncology Group" with 7 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Novartis Pharmaceuticals" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Cancer Network at St. Luke's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Cancer Network at St. Luke's Hospital" are "Breast Cancer" (7 trials), "Lung Cancer" (6 trials), "Colorectal Cancer" (3 trials), "Esophageal Cancer" (3 trials) and "Metastatic Cancer" (3 trials). Many other conditions were trialed in "St. Luke's Cancer Network at St. Luke's Hospital" in a lesser frequency.

Most popular intervention types in "St. Luke's Cancer Network at St. Luke's Hospital" are "Drug" (23 trials), "Radiation" (12 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "cetuximab" (4 trials), "Placebo" (3 trials), "bevacizumab" (3 trials), "docetaxel" (3 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Cancer Network at St. Luke's Hospital" are 23 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Cancer Network at St. Luke's Hospital". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in St. Luke's Cancer Network at St. Luke's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Cancer Network at St. Luke's Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".